JOSEPH BALLARD: Open Payments
NPI 1144331943 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,507 in 77 payments from 13 companies in 2025. Trend: 2023 $27 · 2024 $236 · 2025 $1,507
Food & beverage: $1,422Education: $85
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $373 |
| Regeneron Healthcare Solutions, Inc. | 13 | $221 |
| ABBVIE INC. | 16 | $205 |
| Janssen Biotech, Inc. | 9 | $193 |
| UCB, Inc. | 7 | $137 |
| Lilly USA, LLC | 7 | $115 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $71 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $47 |
| Kerecis Limited | 3 | $43 |
| Novo Nordisk Inc | 1 | $38 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, Bimzelx, LIBTAYO, EBGLYSS, RINVOQ, ILUMYA.
Industry payments across GA — which companies pay providers there.
